QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in
NASDAQ:AXSM

Axsome Therapeutics SEC Filings & 10K Form

$66.21
-3.97 (-5.66 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$65.81
Now: $66.21
$71.43
50-Day Range
$67.36
MA: $73.12
$79.89
52-Week Range
$35.44
Now: $66.21
$109.53
Volume520,776 shs
Average Volume299,367 shs
Market Capitalization$2.47 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.59

SEC Filings

Axsome Therapeutics (NASDAQ:AXSM) SEC Filings

DateFilerForm TypeView
03/01/2021
4:01 PM
Axsome Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2021
6:28 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
4:17 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
7:32 AM
Axsome Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
Form SC 13G
01/28/2021
6:55 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
5:08 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4/A
12/23/2020
5:08 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4/A
12/08/2020
6:07 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
6:17 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
6:01 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
3:49 PM
Axsome Therapeutics (Filer)
Form 10-Q/A
11/05/2020
4:20 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
4:11 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2020
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2020
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2020
6:10 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2020
6:08 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
3:39 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
7:17 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2020
7:43 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
7:25 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
4:06 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
7:23 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2020
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
7:20 AM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:19 AM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
5:42 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:41 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:40 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
6:04 AM
Axsome Therapeutics (Filer)
Form DEFA14A
05/11/2020
4:12 PM
Axsome Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/11/2020
4:06 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2020
7:00 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:18 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2020
8:47 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2020
8:20 PM
Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:19 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:19 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:19 PM
Axsome Therapeutics (Issuer)
Marek David C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:18 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:17 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
8:17 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
4:29 PM
Axsome Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2020
3:49 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
6:07 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2020
5:51 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
7:45 AM
Axsome Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
01/22/2020
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:08 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:39 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
7:15 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:29 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
7:34 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
7:23 PM
Axsome Therapeutics (Filer)
Form 424B5
12/18/2019
4:41 PM
Axsome Therapeutics (Filer)
Form 424B5
12/16/2019
7:25 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
4:11 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
4:03 PM
Axsome Therapeutics (Filer)
Form S-3ASR
12/03/2019
8:15 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
4:06 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:52 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
6:18 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
6:10 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
6:13 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:45 PM
Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:43 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
3:42 PM
Axsome Therapeutics (Issuer)
Marek David C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
6:16 AM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
6:01 PM
Axsome Therapeutics (Issuer)
Marek David C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
6:00 PM
Axsome Therapeutics (Issuer)
Marek David C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2019
6:07 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:49 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:17 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
6:45 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
6:00 AM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
6:18 AM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
6:00 AM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
5:21 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
5:20 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
5:20 PM
Axsome Therapeutics (Issuer)
POTTER MYRTLE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
5:20 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:53 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
6:19 AM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:21 AM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:59 PM
Axsome Therapeutics (Filer)
Form 424B5
05/09/2019
6:36 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
6:11 AM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.